Immune intervention with anti-CD3 in diabetes.
作者信息
Harlan David M, von Herrath Matthias
出版信息
Nat Med. 2005 Jul;11(7):716-8. doi: 10.1038/nm0705-716.
PMID:16015359
Abstract
摘要
相似文献
1
Immune intervention with anti-CD3 in diabetes.
Nat Med. 2005 Jul;11(7):716-8. doi: 10.1038/nm0705-716.
2
Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Int Rev Immunol. 2005 Sep-Dec;24(5-6):327-39. doi: 10.1080/08830180500379697.
3
[Pre-diabetes type 1. Evaluation of current clinical trials].
Journ Annu Diabetol Hotel Dieu. 1997:201-5.
4
Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
Diabetes. 2007 Aug;56(8):2103-9. doi: 10.2337/db06-1632. Epub 2007 Apr 24.
5
Strategies for preventing type I diabetes mellitus.
West J Med. 1996 Mar;164(3):249-55.
6
[Anti-CD3 monoclonal antibodies: a new step towards therapy in new-onset type 1 diabetes].
Med Sci (Paris). 2006 Jan;22(1):5-6. doi: 10.1051/medsci/20062215.
7
CD3-specific antibodies: a portal to the treatment of autoimmunity.
Nat Rev Immunol. 2007 Aug;7(8):622-32. doi: 10.1038/nri2134. Epub 2007 Jul 20.
8
Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.
Curr Diab Rep. 2004 Apr;4(2):85-6. doi: 10.1007/s11892-004-0061-1.
9
Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes.
Ann N Y Acad Sci. 2006 Oct;1079:369-73. doi: 10.1196/annals.1375.057.
10
CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes.
Adv Immunol. 2008;100:13-37. doi: 10.1016/S0065-2776(08)00802-X.
引用本文的文献
1
Recent advances in coeliac disease.
Gut. 2006 Jul;55(7):1037-46. doi: 10.1136/gut.2005.075119.
2
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
J Clin Invest. 2006 May;116(5):1371-81. doi: 10.1172/JCI27191. Epub 2006 Apr 20.
Zotero 插件